1. Cells. 2022 Apr 30;11(9):1503. doi: 10.3390/cells11091503.

The Autophagy Protein Pacer Positively Regulates the Therapeutic Potential of 
Mesenchymal Stem Cells in a Mouse Model of DSS-Induced Colitis.

Bergmann CA(1), Beltran S(1)(2), Vega-Letter AM(3)(4), Murgas P(1)(2)(5), 
Hernandez MF(1), Gomez L(1), Labrador L(1), Cortés BI(1), Poblete C(6), Quijada 
C(7), Carrion F(8)(9), Woehlbier U(1)(5), Manque PA(1)(10)(11).

Author information:
(1)Center for Integrative Biology (CIB), Faculty of Science, Universidad Mayor, 
Santiago 7500000, Chile.
(2)Escuela de Tecnología Médica, Universidad Mayor, Santiago 7500000, Chile.
(3)Laboratorio de Inmunología Celular y Molecular, Centro de Investigación 
Biomédica, Facultad de Medicina, Universidad de Los Andes, Santiago 7620001, 
Chile.
(4)Centro de Investigación e Innovación Biomédica, Universidad de los Andes, 
Santiago 7620157, Chile.
(5)Escuela de Biotecnología, Facultad de Ciencias, Universidad Mayor, Santiago 
7500000, Chile.
(6)Laboratorio de Morfofisiopatología y Citodiagnóstico, Escuela de Tecnología 
Médica, Facultad de Ciencias, Universidad Mayor, Santiago 7500000, Chile.
(7)Servicio de Anatomía Patológica, Hospital Clínico de la Universidad de Chile, 
Santiago 8380456, Chile.
(8)Programa de Inmunología Translacional, Facultad de Medicina, Universidad del 
Desarrollo Clínica Alemana, Santiago 7590943, Chile.
(9)Departamento de Investigación, Postgrado y Educación Contínua (DIPEC), 
Facultad de Ciencias de la Salud, Universidad del Alba, Santiago 8320000, Chile.
(10)Center for Genomics and Bioinformatics (CGB), Faculty of Science, 
Universidad Mayor, Santiago 7500000, Chile.
(11)Centro de Oncologia de Precision (COP), Escuela de Medicina, Universidad 
Mayor, Santiago 7500000, Chile.

Mesenchymal stem cells (MSC) have emerged as a promising tool to treat 
inflammatory diseases, such as inflammatory bowel disease (IBD), due to their 
immunoregulatory properties. Frequently, IBD is modeled in mice by using dextran 
sulfate sodium (DSS)-induced colitis. Recently, the modulation of autophagy in 
MSC has been suggested as a novel strategy to improve MSC-based immunotherapy. 
Hence, we investigated a possible role of Pacer, a novel autophagy enhancer, in 
regulating the immunosuppressive function of MSC in the context of DSS-induced 
colitis. We found that Pacer is upregulated upon stimulation with the 
pro-inflammatory cytokine TNFα, the main cytokine released in the inflammatory 
environment of IBD. By modulating Pacer expression in MSC, we found that Pacer 
plays an important role in regulating the autophagy pathway in this cell type in 
response to TNFα stimulation, as well as in regulating the immunosuppressive 
ability of MSC toward T-cell proliferation. Furthermore, increased expression of 
Pacer in MSC enhanced their ability to ameliorate the symptoms of DSS-induced 
colitis in mice. Our results support previous findings that autophagy regulates 
the therapeutic potential of MSC and suggest that the augmentation of autophagic 
capacity in MSC by increasing Pacer levels may have therapeutic implications for 
IBD.

DOI: 10.3390/cells11091503
PMCID: PMC9101276
PMID: 35563809 [Indexed for MEDLINE]

Conflict of interest statement: The authors declare no conflict of interest.